Literature DB >> 34078404

The occurrence of coronary artery lesions in Kawasaki disease based on C-reactive protein levels: a retrospective cohort study.

Hyo Soon An1, Gi Beom Kim2, Mi Kyoung Song1, Sang Yun Lee1, Hye Won Kwon1, Joo Won Lee1, Eun Jung Bae1.   

Abstract

BACKGROUND: This study aimed to assess the occurrence of coronary artery lesions (CAL) in patients with Kawasaki disease (KD) according to serum C-reactive protein (CRP) levels.
METHODS: This retrospective analysis was based on the nationwide survey of KD conducted in the Republic of Korea between 2015 and 2017. We enrolled 9131 patients and defined low (< 3 mg/dL) and high (≥3 mg/dL) CRP groups. Demographic data, clinical characteristics, z-scores, and scores based on the Japanese criteria for CAL were compared between the two groups. Logistic regression analysis was used to identify CAL risk factors.
RESULTS: The low CRP group accounted for 23% of patients. The mean age at diagnosis was higher in high CRP group compared to the low CRP group (34.4 ± 24.9 vs 31.7 ± 24.8 months, p < 0.001). Fever duration before treatment was not significantly different between the two groups (5.1 ± 1.7 days vs. 5.2 ± 2.1 days; p = 0.206). A non-response to intravenous immunoglobulin treatment was found in 1377 patients (20.1%) and 225 patients (11.7%) in the high and low CRP groups, respectively (p < 0.001). CAL were found in 12.9 and 18.3% of the high and low CRP patients, respectively (p < 0.001), based on z-scores; and in 9.9 and 12.5%, respectively (p = 0.001), based on the Japanese criteria in the acute phase. The giant coronary artery aneurysm occurrence ratio was similar between groups (p = 1.0).
CONCLUSIONS: CAL occurred in patients with both high and low CRP. Therefore, patients with KD should be carefully monitored regardless of their CRP levels.

Entities:  

Keywords:  Acute-phase reactants; Coronary aneurysm; Intravenous immunoglobulins; Mucocutaneous lymph node syndrome; Risk factors

Year:  2021        PMID: 34078404     DOI: 10.1186/s12969-021-00566-6

Source DB:  PubMed          Journal:  Pediatr Rheumatol Online J        ISSN: 1546-0096            Impact factor:   3.054


  11 in total

1.  New equations and a critical appraisal of coronary artery Z scores in healthy children.

Authors:  Frédéric Dallaire; Nagib Dahdah
Journal:  J Am Soc Echocardiogr       Date:  2010-11-13       Impact factor: 5.251

2.  Serum C-reactive protein levels in patients with Kawasaki disease: from the results of nation-wide surveys of Kawasaki disease in Japan.

Authors:  H Koyanagi; H Yanagawa; Y Nakamura; M Yashiro
Journal:  Acta Paediatr       Date:  1997-06       Impact factor: 2.299

3.  Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.

Authors:  Kimiyasu Egami; Hiromi Muta; Masahiro Ishii; Kenji Suda; Yoko Sugahara; Motofumi Iemura; Toyojiro Matsuishi
Journal:  J Pediatr       Date:  2006-08       Impact factor: 4.406

4.  Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.

Authors:  Satoru Iwashima; Mituaki Kimura; Takamichi Ishikawa; Takehiko Ohzeki
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

5.  Epidemiology and Clinical Features of Kawasaki Disease in South Korea, 2012-2014.

Authors:  Gi Beom Kim; Sohee Park; Lucy Youngmin Eun; Ji Whan Han; Soo Young Lee; Kyung Lim Yoon; Jeong Jin Yu; Jong-Woon Choi; Kyung-Yil Lee
Journal:  Pediatr Infect Dis J       Date:  2017-05       Impact factor: 2.129

Review 6.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

7.  A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.

Authors:  Alolika Nandi; Priyankar Pal; Surupa Basu
Journal:  Rheumatol Int       Date:  2019-07-13       Impact factor: 2.631

8.  Fever pattern and C-reactive protein predict response to rescue therapy in Kawasaki disease.

Authors:  Yu Nakagama; Ryo Inuzuka; Taiyu Hayashi; Takahiro Shindo; Yoichiro Hirata; Nobutaka Shimizu; Jun Inatomi; Yoshiki Yokoyama; Yoshiyuki Namai; Yoichiro Oda; Masaru Takamizawa; Yutaka Harita; Akira Oka
Journal:  Pediatr Int       Date:  2016-02-23       Impact factor: 1.524

9.  Kawasaki disease in infants below 6 months: a clinical conundrum?

Authors:  Surjit Singh; Sikha Agarwal; Sagar Bhattad; Anju Gupta; Deepti Suri; Amit Rawat; Manphool Singhal; Manojkumar Rohit
Journal:  Int J Rheum Dis       Date:  2016-03-16       Impact factor: 2.454

Review 10.  Biomarkers for Kawasaki Disease: Clinical Utility and the Challenges Ahead.

Authors:  Himanshi Chaudhary; Johnson Nameirakpam; Rajni Kumrah; Vignesh Pandiarajan; Deepti Suri; Amit Rawat; Surjit Singh
Journal:  Front Pediatr       Date:  2019-06-18       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.